- Home
- TLSI vs TSSI Comparison
TLSI vs TSSI Comparison
Compare TLSI & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | TSSI |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 252.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | TSSI |
|---|---|---|
| Price | $7.26 | $7.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | 175.5K | ★ 2.0M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.63 |
| EPS | N/A | ★ 0.19 |
| Revenue | $40,207,000.00 | ★ $234,837,000.00 |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | N/A |
| P/E Ratio | ★ N/A | $40.21 |
| Revenue Growth | 49.52 | ★ 91.66 |
| 52 Week Low | $3.42 | $5.63 |
| 52 Week High | $7.70 | $31.94 |
Technical Indicators
Market Signals| Indicator | TLSI | TSSI |
|---|---|---|
| Relative Strength Index (RSI) | 68.96 | 27.83 |
| Support Level | $6.06 | $8.60 |
| Resistance Level | $7.70 | $9.48 |
| Average True Range (ATR) | 0.58 | 0.57 |
| MACD | 0.07 | 0.15 |
| Stochastic Oscillator | 81.08 | 0.88 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About TSSI TSS Inc.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.